Donald Healey's most recent trade in Adicet Bio Inc was a trade of 43,361 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Donald Healey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 43,361 | 43,361 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Donald Healey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 24 Jan 2026 | 535 | 3,452 | - | 8.4 | 4,515 | Common Stock |
| Adicet Bio Inc | Donald Healey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Donald Healey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 24 Jan 2025 | 8,560 | 63,769 | - | 0.9 | 7,891 | Common Stock |
| Adicet Bio Inc | Donald Healey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 271,595 | 271,595 | - | - | Stock Option (Right to Buy) |